---
title: "This Charles River Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290058457.md"
description: "Wall Street analysts upgraded four stocks on Wednesday. BTIG's Douglas Harter upgraded MITT and MFA to Buy with price targets of $9 and $10.50, respectively. Morgan Stanley's Jorge Kuri upgraded Credicorp (BAP) to Overweight, raising the target to $480. Additionally, Morgan Stanley's Ricky Goldwasser upgraded Charles River Laboratories (CRL) to Overweight, increasing its price target from $185 to $220."
datetime: "2026-06-17T13:08:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290058457.md)
  - [en](https://longbridge.com/en/news/290058457.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290058457.md)
generator: "portal-rs"
---

# This Charles River Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   BTIG analyst Douglas Harter upgraded **TPG Mortgage Investment Trust Inc** (NYSE:MITT) from Neutral to Buy and announced a $9 price target. TPG Mortgage Investment shares closed at $7.94 on Tuesday. See how other analysts view this stock.
-   BTIG analyst Douglas Harter upgraded **Mfa Financial Inc** (NYSE:MFA) from Neutral to Buy and announced a $10.5 price target. MFA Finl shares closed at $9.38 on Tuesday. See how other analysts view this stock.
-   Morgan Stanley analyst Jorge Kuri upgraded **Credicorp Ltd** (NYSE:BAP) from Equal-Weight to Overweight and raised the price target from $375 to $480. Credicorp shares closed at $364.28 on Tuesday. See how other analysts view this stock.
-   Morgan Stanley analyst Ricky Goldwasser upgraded **Charles River Laboratories International, Inc.** (NYSE:CRL) from Equal-Weight to Overweight and raised the price target from $185 to $220. Charles River shares closed at $184.79 on Tuesday. See how other analysts view this stock.

Considering buying MFA stock? Here’s what analysts think: 

*Photo via Shutterstock*

### Related Stocks

- [MITT.US](https://longbridge.com/en/quote/MITT.US.md)
- [MFA.US](https://longbridge.com/en/quote/MFA.US.md)
- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [BAP.US](https://longbridge.com/en/quote/BAP.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [MITT-C.US](https://longbridge.com/en/quote/MITT-C.US.md)
- [MITP.US](https://longbridge.com/en/quote/MITP.US.md)
- [MITT-A.US](https://longbridge.com/en/quote/MITT-A.US.md)
- [MITN.US](https://longbridge.com/en/quote/MITN.US.md)
- [MITT-B.US](https://longbridge.com/en/quote/MITT-B.US.md)
- [MFAN.US](https://longbridge.com/en/quote/MFAN.US.md)
- [MFAO.US](https://longbridge.com/en/quote/MFAO.US.md)
- [MFA-B.US](https://longbridge.com/en/quote/MFA-B.US.md)
- [MFA-C.US](https://longbridge.com/en/quote/MFA-C.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Charles River expands Endosafe cartridge output with automated manufacturing suite](https://longbridge.com/en/news/298315263.md)
- [MFA Financial (NYSE:MFA) Hits New 12-Month Low  - What's Next?](https://longbridge.com/en/news/298615400.md)
- [Baird Just Upgraded Deere Stock. Here's Why.](https://longbridge.com/en/news/297677018.md)
- [Credicorp (BAP) to Release Quarterly Earnings on Thursday](https://longbridge.com/en/news/295072368.md)
- [HighTower Advisors LLC Purchases 9,240 Shares of Philip Morris International Inc. $PM](https://longbridge.com/en/news/298200198.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**